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SAFETY AND HYPOGLYCAEMIC PROPERTIES OF AQUEOUS LEAF EXTRACT 
OF OCIMUM GRATISSIMUM IN STREPTOZOTOCIN INDUCED DIABETIC 
RATS.
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Summary: The claim by Nigerian traditional herbal medicine practitioners that Ocimum gratissimum leaves 
have antidiabetic properties was investigated.  Diabetes mellitus was induced with streptozotocin and graded 
doses of the aqueous leaf extract were administered orally to the experimentally diabetic rats for 28 days. 
Administration of the aqueous leaf extract caused a statistically significant reduction in plasma glucose level in 
streptozotocin induced diabetic rats.  The extract appeared nontoxic as evidenced by normal serum levels of 
AST, ALT, ALP, TPT, ALB and bilirubin.  These data appear to agree with claimed hypoglycaemic effects of 
Ocimum gratissimum.
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Introduction
Information is scanty on the use of Ocimum 
gratissimum as a medicinal plant. Available 
information reported Sofawora, (1982) was that 
the leaves of the plant are used by different tribes 
for different purposes in West Africa and 
Nigeria. This plant is a shrubbery herb in the 
family of Lamiaceae. It is used for the treatment 
of bacterial infections, fever, diarrhoea and as a 
spice. The various local names in Nigeria are as 
follows;  Daidoya (Hausa); Nchuanu (Igbo); 
Efinrin (Yoruba). This plant has been recently 
claimed to be useful in the treatment of diabetes 
(personal communication from Dr. Alzija, 
traditional practitioner in the Department of 
Pharmacology, University of Jos-Nigeria). 
However, no scientific data are available on the 
efficacy and safety to support this claim. 
Although Aguiyi et al (2000) recently reported 
hypoglycaemic activities of Ocimum 
gratissimum in alloxan- induced diabetic rats,  
reports on its safety have not been documented.
The objective of the present study is directed 
towards evaluating the efficacy and safety of the 
plant as claimed by the herbal practitioners in the 
management of diabetes mellitus using 
streptozotocin induced  diabetic rats.
Materials and Methods
Collection and identification of plant materials
The fresh leaves of the shrub were collected 
from the University of Jos. The leaves were 
identified and authenticated as Ocimum 
gratissimum leaves by Professor C. Akueshi, a 
plant taxonomist in the Department of Botany, 
Faculty of Natural Sciences, University of Jos, 
Nigeria. It was deposited as voucher specimen 
for future reference in the Department of Human 
Physiology, University of Jos.
Preparation of Extract
Fresh leaves of Ocimum gratissimum 
were air dried and ground into coarse powder. 
Eight hundred grams of the powdered leaves was 
stirred into 450mls of boiling distilled water. The 
boiling was allowed to continue for 5 minutes. It 
was then filtered through a fine sieve. The filtrate 
was cooled. The solution was centrifuged at 
4000 rpm for 10 minutes in a refrigerated 
centrifuge. The Supernatant was collected dried 
in vacuo using a rotary film evaporator. The 
residue was weighed and dissolved in a known 
volume of distilled water to give a concentration 
of 500mg/ml. It was kept frozen at  4oC and used 
in subsequent experiments.
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Induction of Diabetes
Diabetes mellitus was induced in rats by 
single intraperitoneal injection of 70mg/kg 
streptozotocin supplied by Dr. J. C. Aguiyi  of 
University of Jos, dissolved in 0.1M citrate 
buffer pH 4.5. Effectiveness of the drug was 
confirmed by the presence of high fasting plasma 
glucose level determined 24 and 48 hours after 
the injection. Graded doses of the aqueous 
extract were given to the rats. Body weight, fluid 
intake and food consumption patterns were 
monitored during the 28 day experimentation 
period.
Treatment of Animals
The experimental animals used for this 
study were locally bred male wistar strain rats 
from the animal house of University of Jos –
Nigeria. Rats of body weight (150-200g) and 8 
weeks old were used.  The animals maintained 
under standard environmental conditions had 
free access to food (Grand cereal products, Jos , 
Nigeria) and water ad libitum. Eighteen groups 
of five rats each were distributed in cages and 
acclimatized for 48 hours. The groups were then 
treated as follows; Groups 1-3 were control 
groups receiving only water groups 4-6 were 
extract treated control rats receiving 250mg/kg 
every 3 days groups 7-18 were streptozotocin –
induced diabetic rats dose 70mg/kg. Groups 7-9 
received 500mg/kg extract daily, 10-12 received 
1000mg/kg extract daily, 13-15 received 
1500mg/kg extract daily while 16-18 received 
only water.
Rats were then housed in metabolic cages 
(Becker and Co GmBH animal cage model III F 
75) to facilitate urine collection without faecal 
contamination.  Following ether anaesthetization 
blood samples were collected at 1, 14 and 28 
days by cardiac puncture for glucose estimation. 
Thereafter the animals were sacrificed.
Toxicity testing (Time Course effects of selected 
doses).  
Four groups of twenty rats per group were 
acclimatized. Each group of rat received between 
500-1500mg/kg extract daily for 28 days. The 
control group of rats received water as their only 
source of fluid. Groups of rats were sacrificed by 
ether anaesthetization at days 0, 7, 14 and 28   
after a extract administration and blood collected 
by cardiac puncture for estimation of ALT, AST 
ALP, Bilirubin, Albumin and Total protein.
Collection, preparation and analysis of blood 
samples
Blood was separately collected from each 
diabetic and non diabetic rat on the days stated 
above. Blood was allowed to clot and serum 
separated by centrifugation at 3500 rpm for 10 
minutes(JICA, Japan) for the Biochemical 
parameters.  
The serum was assayed either 
immediately or stored at–20 oC. Glucose 
concentration was determined by the glucose 
oxidase method of Trinder (1969). Alanine and 
aspartate transaminase (ALT, AST) levels were 
determined by the method of BergMeyer and 
Bernt, (1974) and alkaline phosphatase (ALP) by 
the procedure of King and kind (1954). Bilirubin 
was determined spectrophotometrically by the 
modified method of Malloy and Evelyn, (1937).  
Total protein was determined by the biuret 
method (Amstrong and Carr, 1960). Serum 
Albumin was determined by the dye bind 
method (Gowenlock, 1988).
Statistical Analysis of Data Data were analyzed 
using Students’ t-test. P-value of 0.05 or less was 
considered to be significant. 6
Results
Induction of diabetes in the experimental 
rats was confirmed by the presence of high 
plasma glucose level as shown in Table 1. The 
difference between the experimental and control 
rats was statistically significant (P < 0.05). No 
deaths were  recorded during the experimental 
period.  The effect of the extract on plasma 
glucose level of non-diabetic control, extract 
treated control and streptozotocin induced 
diabetic rats is shown in Table 2.
The levels of glucose in normal rats 
receiving the extract did not differ significantly 
from control rats without extract treatment. 
However, there was significant difference (P < 
0.05) between the level of glucose in diabetic 
and normal rats and also between diabetic 
control rats and diabetic rats on the extract.
Increasing the concentration of the extract 
produced a dose and time dependent decrease in 
plasma glucose level over the 28-day period of 
administration of the extract.  The values 
obtained for blood glucose in extract treated 
diabetic rats on day 14 and 28 were significantly 
lower ( P < 0.05)  compared with diabetic 
control.  The concentrations of the indices of 
toxicity determined by the estimation of ALT, 
AST, ALP, TPT, ALB and bilirubin were not 
significantly different (P > 0.05) from the control 
(Table 3).
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Table 1: Serum glucose levels in Streptozotocin- induced diabetic rats 24h and 48h after induction
Group 24h glucose(mmol/L) 48h glucose(mmol/L)
Non Diabetic(control) 4.20 ± 0.12 4.60 ± 0.11
Diabetic(test) 8.40 ± 0.11 a 8.60 ± 0.42 a
Mean ±SEM for  five determinations a   P <  0.01  Significantly higher in diabetic(test) compared to non 
diabetic rats(controls).
Table 2: Effect of Oral administration of aqueous extract of Ocimum gratissimum on plasma glucose level of 
non diabetic control, Extract treated control and streptozotocin induced diabetic rats on Day 1, 14 and 
28.
Plasma glucose   Concentration(mmol/L)   n  = 5)
Groups Day 1 Day 14 Day 28
Control 4.40 ± 0.11 4.20 ± 0.15 4.40 ± 0.12
Non diabetic + 250mg/kg 
extract every 3 days
4.67 ± 0.24 4.93 ± 0.24 4.87± 0.1
Diabetic control 8.60 ± 0. 42 a 8.27 ± 0. 18 a 8.87 ± 0. 35 a
Diabetic rats + 500mg/kg 
extract
8.60 ± 0. 12 a 6.36 ± 0. 27 a, b 5.33 ± 0. 18 a, b
Diabetic rats + 1000mg/kg 
extract
8.20 ± 0. 11 a 5.30 ± 0. 17 a, b 5.30 ± 0. 15 a, b
Diabetic rats  + 1500mg/kg 
extract
8.66 ± 0. 41 a 5.60 ± 0. 12 a, b 5. 0 ± 0. 12 a, b
Mean ± SEM for  five determinations .a P <  0.05  Significantly higher compared  with normal rats 
b P <  0.05 significant as compared with diabetic control rats
Table 3: Effect  of  oral administration of (varying doses) of Ocimum gratissimum on Serum levels of ALP, ALT, 
AST,TPT, ALB, TBL on normal rats
Day Dose 
(mg/Kg)
IU/L  g/L  mmol/L
ALP ALT AST TPT (g/L) ALB (g/L) TB(umol/L) 1.9 ± 0.06
      0 218.7 ±9.40 71.3 ±0.67 272.0 ±1.15 66.0 ±0.00 33.0 ± 0.58 2.0± 0.00
0   500 218.7 ±9.40 70.7 ±0.67 271.6 ±0.88 52.0 ±0.00 32.7± 1.45 2.1± 0.45
1000 204.3 ±29.47 72.0 ±1.15 123.3 ±3.33 19.0 ±0.00 32.6± 1.76 2.0± 0.28
1500 214.3 ±7.21 72.7 ±2.67 266.3 ±9.13 41.0 ±0.00 32..3± 7.88 1.8± 0.14
      0 251.0 ±1.00 81.7 ±0.88 262.7 ±8.19 55.0 ±2.88 39.0±. 2.08 1.9± 0.06
7   500 54.3 ±16.69 283.0 ±7.00 256.7 ±21.85 55.0 ±2.88 38.3±1.67 1.9± 0.06
1000 250.0 ±17.32 84.0 ±2.64 260.3 ±20.49 56.7 ±2.96 36.7±2.40 2.0± 0.08
1500 250.0 ±5.77 81.7 ±1.67 253.3 ±17.63 54.3±2.84 39.8±.0.67 2.1± 0.05
      0 187.7 ±20.21 74.0 ±7.02 301.3 ±12.34 52.3 ±1.45 33.0±1.52 2.1± 0.05
14   500 185.0 ±19.13 75.7 ±6.69 326.0 ±41.10 51.3 ±0.88 31.7±0.88 2.0± 0.00
1000 189.7 ±17.32 73.0 ±6.50 297.6 ±9.59 52.7 ±1.20 32.0±. 1.45 2.2± 0.08
1500 186.0 ±18.55 70..7 ±5.20 306.0±8.72 52.3 ±1.45 32.3±1 .45 2. 0± 0.03
     0 257.0 ±2.08 74.7 ±4.37 246.0 ±16.00 550 ±3.51 36.7±1.20 1.8± 0.0
28   500 244. ±12.7 64.7 ±2.90 244.0 ±14.00 55.6 ±3.28 34.7±0.33 2.0± 0.13
1000 211.3 ±22.04 66.8 ±4.05 241.7 ±16.29 55.0±3.51 35.7±. 1.20 1.7± 0.20
1500 257.7 ±17.57 75.3±5.69 239.7±15.38 50.3 ±1.20 39.0±0 .57
 Serum (Levels (Mean ± SEM, n = 5)  P < 0.05 Comparison of experimental and control group 
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Discussion 
Ociumum gratissimum is widely distributed 
throughout Central America, West African coast 
and has been used in Trinidad and Tobago and in 
Nigeria for the treatment of various ailments 
including diabetes mellitus (Bailey and Day, 
1989; Aguiyi et al, 2000) This work reports the 
results of preliminary investigation into the 
efficacy of the use of O. gratissimum in treating 
diabetes mellitus as well as the assessment of  
safety of the leaf extract using rats. The aqueous 
extract did not exert significant side effect on the 
vital organs of the  body as determined by 
biochemical indices (Dossing and Anderson, 
1986).  
The results of preliminary investigation of 
the hypoglycaemic property of the plant showed 
that the plant is an effective antidiabetic agent. 
The administration of graded doses of the 
aqueous leaf extract produced a statistically 
significant decrease (P < 0.05) in serum glucose 
concentration when compared with diabetic 
control rats and normal control rats.
Twenty eight day administration of the 
extract to non diabetic rats did not produce any 
significant difference in the plasma glucose 
concentration of non diabetic extract treated rats 
compared with control. The mechanism of the 
hypoglycaemic effects of the aqueous extract of 
this plant is not clear at the moment. However, 
reports are available to show that antidiabetic 
plants may affect circulating insulin level 
(Lamela et al, 1985).  Studies have shown that 
free radicals can cause disruption in insulin 
action and mitigate glucose tolerance states 
(Ford, 1999). It is also possible that treatment 
with O. gratissimum could be facilitating 
utilization of glucose by peripheral tissues. This 
mechanism has been observed in the use of 
infusion of African mistletoe (Obatomi et al,
1994) and aqueous bark extract of Ceiba 
pentandra (Ladeji et al, 2003) in the treatment of 
diabetes mellitus. The mechanism of action was 
however, not investigated owing to technical 
reasons. 
The statistically significant high glucose 
level observed in plasma of streptozotocin 
induced diabetic rats indicate establishment of a 
diabetic state. However, in streptozotocin-
induced diabetic rats, administration of graded 
doses of the aqueous extract produced a gradual 
decrease in plasma glucose levels from 1 to 14 
and 28 days. The gradual decrease in plasma 
glucose levels may be due to the fact that O. 
gratissimum could be facilitating utilization of 
glucose by peripheral tissue. It is important to 
note that the plant extract contains flavonoids 
and other phytochemical constituents believed to 
be responsible for its hypoglycaemic property 
(Oladele et al, 1995). The extract also contains 
major mineral elements e.g. Calcium, chloride, 
manganese, magnesium, zinc and potassium 
which might also play a contributory role in 
enhancing medicinal properties such as the 
hypoglycaemic property (Chen et al, 1995).
The comparable values for indices of 
toxicity in the cell (AST, ALT, ALP, TPT, ALB 
and Bilirubin) between diabetic and non-diabetic 
extract treated rats suggests that the extract may 
not be toxic at least to the liver at the 
concentration employed (Dossing and Anderson 
1986).
We conclude that since the aqueous leave 
extract of O. gratissimum given orally for a 
period of 28 days produced a decreased plasma 
glucose level and it does not appear to be toxic, 
the plant has a hypoglycacmic effect and may be 
safe when taken orally if the results obtained 
with rats are applicable to man.
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